The decline in Dynavax Technologies' stock price following the release of preliminary guidance suggests that the market may have had higher expectations for the company's financial performance. Preliminary guidance often serves as an indicator of what the company expects to report, and a negative market reaction can imply that the guidance did not meet investor expectations. This could lead to a short-term negative impact on the stock price as investors adjust their positions based on the new information.